Clinical Trial Update: Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients [Phase 1]

View source ↗

Summary

An early-phase (Phase I/II) trial of a chemo-immunotherapy combination for melanoma has completed Phase 1, according to the update. The document does not includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Istituto Superiore di Sanità | Conditions: Melanoma | Phase 1 | Status: COMPLETED